Afya Limited — Cyborg Score 8/10

Strong
Medical Education & Healthcare Services

Strategic Profile

Afya controls 3,753 approved medical seats in Brazil's tightly regulated market, where the Ministry of Education strictly limits new medical school capacity, creating a defensible monopoly that maintains 100% occupancy. The company's three-segment structure captures the entire physician lifecycle, creating multiple monetization points per doctor and generating 65% B2B revenue growth in Continuing Education. Afya expanded EBITDA margins by 200 basis points to 46.4% through operational discipline and digital platform optimization, demonstrating pricing power and operational leverage.

Cyborg Score Rationale

Afya demonstrates strong competitive positioning with a regulatory moat, dominant market share in medical education, exceptional EBITDA margins (46.4%), and consistent revenue growth. The integrated physician ecosystem provides sticky B2B growth and diversified revenue streams. Primary risks include regulatory exposure and emerging competition.

Top Insights

  • Regulatory moat: Controls 3,753 approved medical seats with government-restricted capacity, maintaining 100% occupancy rates despite competition
  • Diversified ecosystem: End-to-end physician lifecycle model (undergraduate, residency prep, continuing ed, practice tools) creates multiple B2B/B2C revenue streams
  • Margin expansion: EBITDA margins reached 46.4% through operational efficiency and digital platform optimization, demonstrating significant operating leverage
  • Active acquisition strategy: Recently closed acquisitions (Unidom 300 seats, Faculdade Masterclass 60 seats) with 3,593 total approved seats across campuses

Named Competitors

  • Medical Education Services — Private equity-backed education services provider based in Florianopolis, Brazil
  • Broader Education Services — Generalist education company diluting focus across multiple disciplines
  • Broader Education Services — Diversified education provider across business, engineering and other programs

Recent Developments

  • (May 2025) Closed acquisition of Faculdade Masterclass adding 60 medical school seats in Contagem, Belo Horizonte metropolitan area
  • (October 2024) Announced 5.1% tuition fee increase for new students in 2025, above inflation expectations, reflecting brand strength
  • (September 2025) Reported 16.3% YoY revenue growth and 25.0% YoY EBITDA growth for Q3 2024; completed Unidom acquisition adding 300 seats

Open the full interactive Afya Limited report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →